Milestone Pharmaceuticals said on Friday that the U.S. health regulator had declined to approve its nasal spray to treat a type of heart condition and had called for an inspection of the facility that ...

It also affirms the organization's ongoing efforts to improve patient outcomes and enhance care coordination for one of the most prevalent life-limiting illnesses in the United States. "Many patients ...

Despite being the most common cause of death in the United States, heart failure remains underrepresented in hospice care. Studies suggest only one in 10 patients with advanced heart failure is ...